The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index; none of the 257 sources its claims cite is checked for support yet.
The Airway Epithelium: Soldier in the Fight against Respiratory Viruses
Open accessAbstract
SUMMARY: The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological functions. It initiates multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. The interaction between respiratory viruses and airway epithelial cells results in production of antiviral substances, including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, and also in production of cytokines and chemokines, which recruit inflammatory cells and influence adaptive immunity. These defense mechanisms usually result in rapid virus clearance. However, respiratory viruses elaborate strategies to evade antiviral mechanisms and immune responses. They may disrupt epithelial integrity through cytotoxic effects, increasing paracellular permeability and damaging epithelial repair mechanisms. In addition, they can interfere with immune responses by blocking interferon pathways and by subverting protective inflammatory responses toward detrimental ones. Finally, by inducing overt mucus secretion and mucostasis and by paving the way for bacterial infections, they favor lung damage and further impair host antiviral mechanisms.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that the airway epithelium is a central frontline defender against respiratory viruses through physical barrier, mucociliary clearance, and innate/adaptive immune functions, but that viruses subvert these defenses to cause epithelial damage, dysregulated inflammation, mucus obstruction, and secondary bacterial infection. It synthesizes mechanisms of epithelial protection and viral evasion and discusses therapeutic implications.
Key findings
- The airway epithelium defends against respiratory viruses via cell-cell junctions, the mucociliary escalator, and immune recognition through TLRs and intracellular sensors such as RIG-I/MDA5; it produces antiviral substances including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, plus cytokines/chemokines that recruit innate and adaptive immune cells.
- Respiratory viruses evade these defenses by inhibiting IFN synthesis or downstream signaling (e.g., RSV NS2 targets RIG-I; RSV NS1/NS2 inhibit STAT2; influenza NS1 inhibits PKR), disrupting tight junctions and epithelial repair, shifting Th1 responses toward Th2, and inducing mucus hypersecretion and mucostasis.
- Viral respiratory tract infections are the most common illnesses worldwide; rhinoviruses are the most frequent agents, and vRTIs are linked to exacerbations of asthma, cystic fibrosis, and COPD and to later recurrent wheeze/asthma risk. The paper reports that vRTIs lead to more than 400,000 hospitalizations per year among children in the United States.
- Viruses promote secondary bacterial infection: during influenza pandemics, bacterial coinfections with *Streptococcus pneumoniae*, *Haemophilus influenzae*, and *Staphylococcus aureus* contributed importantly to mortality, and the majority of deaths during the 1918–1919 flu pandemic were due to bacterial pneumonia. Mechanisms include decreased clearance, increased paracellular permeability, and virus-induced bacterial adherence.
Methods
- Design: narrative review.
- Data or sample: published literature on airway epithelial defense and respiratory virus pathogenesis; no primary cohort, experimental sample, or statistical analysis is reported.
- Main analysis: thematic synthesis of epithelial barrier, mucociliary, innate, and adaptive immune mechanisms, viral evasion strategies, and pathways promoting bacterial infection; includes summary tables of the “wounded soldier” model and studies on bacterial adherence to human respiratory epithelial cells during viral infection.
Limitations
- The paper does not state limitations.
- Evident from the text: as a narrative review, it does not describe a systematic search strategy, inclusion criteria, or quantitative synthesis, and it relies on heterogeneous in vitro, animal, and clinical studies.
- Evident from the text: several mechanisms are explicitly described as unresolved or speculative, including whether NLRP3 directly senses viral RNA, the role of airway epithelial cell-induced inflammation in virus-specific disease severity, and whether high inflammatory mediator levels reflect dysregulated inflammation versus increased viral replication.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 257 cited sources checked · 0 supported · 0 flagged
None of the sources cited for this claim have been checked yet.
In the paper
“Airway mucin production is induced by many respiratory viruses, including rhinovirus and influenza virus (278, 336).”
What the sources say
- Not checked yetcites [278] Tamura, S., and T. Kurata. 2004. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57:236-247. [PubMed] [Google Scholar] source
- Not checked yetcites [336] Zhu, L., P. K. Lee, W. M. Lee, Y. Zhao, D. Yu, and Y. Chen. 2009. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am. J. Respir. Cell Mol. Biol. 40:610-619. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“They are attached to their neighbors by cell-cell junctions, including tight junctions (TJs), adherens junctions (AJs), gap junctions, and desmosomes (234).”
What the sources say
- Not checked yetcites [234] Roche, W. R., S. Montefort, J. Baker, and S. T. Holgate. 1993. Cell adhesion molecules and the bronchial epithelium. Am. Rev. Respir. Dis. 148:S79-S82. [DOI] [PubMed] [Google Scholar] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The increased production of mucus allows for better trapping and clearance of viruses.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Airway epithelial cells rapidly recognize pathogens through pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and intracellular viral sensors (3) (Fig. 2).”
What the sources say
- Not checked yetcites [3] Akira, S. 2009. Pathogen recognition by innate immunity and its signaling. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85:143-156. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“TLRs play a crucial role in the initiation of immune responses in the respiratory epithelium (45, 175).”
What the sources say
- Not checked yetcites [45] Diamond, G., D. Legarda, and L. K. Ryan. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173:27-38. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [175] Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145. [DOI] [PubMed] [Google Scholar] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“They hinder viral access to receptors within the epithelial basolateral membrane, which is an important interaction and entry site for several viruses (18, 19).”
What the sources say
- Not checked yetcites [18] Bergelson, J. M. 2009. Intercellular junctional proteins as receptors and barriers to virus infection and spread. Cell Host Microbe 5:517-521. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [19] Bergelson, J. M. 2003. Virus interactions with mucosal surfaces: alternative receptors, alternative pathways. Curr. Opin. Microbiol. 6:386-391. [DOI] [PubMed] [Google Scholar] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, respiratory viruses elaborate strategies to evade antiviral mechanisms and immune responses.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to their physical protective role, airway epithelial cells possess important immune functions in the fight against respiratory viruses.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Airway epithelial cells regulate both innate and adaptive immunity through production of functional molecules and physical interactions with cells of the immune system.”
What the sources say
- Not checked yetcites [108] Hiemstra, P. S. 2001. Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr. Respir. Rev. 2:306-310. [DOI] [PubMed] [Google Scholar] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The interaction between respiratory viruses and airway epithelial cells results in production of antiviral substances, including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, and also in production of cytokines and chemokines, which recruit inflammatory cells and influence adaptive immunity.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclear
- It may state two separate claims as one. 62
- Probably not a substantial claim. 20
In the paper
“Activation of epithelial cells results in immediate host defense responses that include production of antiviral substances as well as proinflammatory cytokines which recruit and activate other mucosal innate immune cells and initiate mechanisms of adaptive immunity (108).”
What the sources say
- Not checked yetcites [108] Hiemstra, P. S. 2001. Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr. Respir. Rev. 2:306-310. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Besides its role in maintaining the conduit for air to and from the alveoli, the airway epithelium is central to the defense of the lung against pathogens, through the combined function of ciliated epithelial and secretory cells maintaining efficient mucociliary clearance and through a variety of other host defense mechanisms (45, 65, 144).”
What the sources say
- Not checked yetcites [45] Diamond, G., D. Legarda, and L. K. Ryan. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173:27-38. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [65] Fokkens, W. J., and R. A. Scheeren. 2000. Upper airway defence mechanisms. Paediatr. Respir. Rev. 1:336-341. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [144] Knight, D. A., and S. T. Holgate. 2003. The airway epithelium: structural and functional properties in health and disease. Respirology 8:432-446. [DOI] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological functions.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Primary human airway epithelial cells and cell lines derived from them have been shown to express 10 TLRs (TLR1 to -10) (188, 260), and TLR expression has been documented for human biopsy tissue (101).”
What the sources say
- Not checked yetcites [188] Muir, A., G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. Van Heeckeren, and A. Prince. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30:777-783. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [260] Sha, Q., A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer. 2004. Activation of airway epithelial cells by Toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31:358-364. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [101] Hauber, H. P., M. K. Tulic, A. Tsicopoulos, B. Wallaert, R. Olivenstein, P. Daigneault, and Q. Hamid. 2005. Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis. Can. Respir. J. 12:13-18. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, by inducing overt mucus secretion and mucostasis and by paving the way for bacterial infections, they favor lung damage and further impair host antiviral mechanisms.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While airway defense mechanisms efficiently fight respiratory viruses most of the time, resulting in rapid clearance of the virus with minimal clinical consequences, viruses have found ways of avoiding immune responses in the airways, with the potential consequence of severe respiratory disease.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, they can interfere with immune responses by blocking interferon pathways and by subverting protective inflammatory responses toward detrimental ones.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Innate immune responses of the epithelium allow for control of viral invasion and replication, and adaptive responses allow for effective viral clearance through cells of the adaptive immune system.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, mucin overproduction and excessive mucus formation can lead to airway obstruction and exacerbation of preexisting airway disease, turning a powerful innate cleaning defense system into a detrimental mechanism (see The Wounded Soldier) (239, 298).”
What the sources say
- Not checked yetcites [239] Rose, M. C., and J. A. Voynow. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86:245-278. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [298] Voynow, J. A., S. J. Gendler, and M. C. Rose. 2006. Regulation of mucin genes in chronic inflammatory airway diseases. Am. J. Respir. Cell Mol. Biol. 34:661-665. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These defense mechanisms usually result in rapid virus clearance.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“They may disrupt epithelial integrity through cytotoxic effects, increasing paracellular permeability and damaging epithelial repair mechanisms.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Type III IFNs possess antiviral properties similar to those of type I IFNs but appear to be expressed especially by epithelial cells and consequently exert host protection primarily at epithelial surfaces (8, 9, 335).”
What the sources say
- Not checked yetcites [8] Ank, N., and S. R. Paludan. 2009. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35:82-87. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [9] Ank, N., H. West, and S. R. Paludan. 2006. IFN-lambda: novel antiviral cytokines. J. Interferon Cytokine Res. 26:373-379. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [335] Zhou, Z., O. J. Hamming, N. Ank, S. R. Paludan, A. L. Nielsen, and R. Hartmann. 2007. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J. Virol. 81:7749-7758. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Binding of RNA species to RIG-I and MDA5 leads to interaction of CARDs within an adaptor protein called IPS-1, MAVS, VISA, or Cardif (222). This outer mitochondrial membrane protein mediates the recruitment and activation of protein kinases that phosphorylate the transcription factor IRF-3, leading to the synthesis of type I and type III IFNs (155).”
What the sources say
- Not checked yetcites [222] Qi, B., Y. Huang, D. Rowe, and G. Halliday. 2007. VISA—a pass to innate immunity. Int. J. Biochem. Cell Biol. 39:287-291. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [155] Le Goffic, R., J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178:3368-3372. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“For example, RSV induces replication-mediated activation of the IFN-β promoter via RIG-I signaling (253).”
What the sources say
- Not checked yetcites [253] Sasai, M., M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177:8676-8683. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“It has been shown that the RSV fusion protein interacts with TLR4, which then signals through MyD88 to induce immune responses in airway epithelial cells (28, 92, 103, 152), and a recent study demonstrated RSV interaction with TLR2 and TLR6, promoting a proinflammatory response (190).”
What the sources say
- Not checked yetcites [28] Boukhvalova, M. S., G. A. Prince, L. Soroush, D. C. Harrigan, S. N. Vogel, and J. C. Blanco. 2006. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 24:5027-5035. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [92] Haeberle, H. A., R. Takizawa, A. Casola, A. R. Brasier, H. J. Dieterich, N. Van Rooijen, Z. Gatalica, and R. P. Garofalo. 2002. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and Toll-like receptor 4-dependent pathways. J. Infect. Dis. 186:1199-1206. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [103] Haynes, L. M., D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp. 2001. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730-10737. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Among them, IFNs, lactoferrin (LF), β-defensins (BDs), and nitric oxide (NO) are considered the most important epithelium-derived antiviral host defense molecules (Fig. 1).”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“TLRs trigger activation predominantly of mitogen-activated protein (MAP) kinases and of several key transcription factors, including NF-κB, interferon regulatory factor 3 (IRF-3), and IRF-7, resulting in the induction of numerous proinflammatory cytokines and type I (α and β) and type III (λ) IFNs (120).”
What the sources say
- Not checked yetcites [120] Iwamura, C., and T. Nakayama. 2008. Toll-like receptors in the respiratory system: their roles in inflammation. Curr. Allergy Asthma Rep. 8:7-13. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In contrast, RIG-I has been shown to detect negative-sense ssRNA viruses that bear a 5′-triphospho-RNA genome, such as influenza virus and RSV, and appears to play a crucial role in the antiviral response to infection with these viruses (138).”
What the sources say
- Not checked yetcites [138] Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C. S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“NLRP3 expression and production of IL-1β are induced in primary human airway epithelial cells in response to influenza A virus infection, but it has yet to be determined whether NLRP3 acts directly as a PRR for viral RNA or if it is activated only indirectly in response to PRR signaling (5).”
What the sources say
- Not checked yetcites [5] Allen, I. C., M. A. Scull, C. B. Moore, E. K. Holl, E. McElvania-TeKippe, D. J. Taxman, E. H. Guthrie, R. J. Pickles, and J. P. Ting. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30:556-565. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“IFN-α and IFN-β were among the first antiviral agents to be characterized and are still seen as central to the early antiviral response of virus-infected cells.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“It prevents entry of virus into the host cell, either by blocking cellular receptors or by direct binding to virus particles (290).”
What the sources say
- Not checked yetcites [290] Van der Strate, B. W., L. Beljaars, G. Molema, M. C. Harmsen, and D. K. Meijer. 2001. Antiviral activities of lactoferrin. Antiviral Res. 52:225-239. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“MDA5 has been shown to detect small RNA viruses such as rhinoviruses and is critical in regulating IFN-β, IFN-λ, and proinflammatory cytokine transcription (138).”
What the sources say
- Not checked yetcites [138] Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C. S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This defective IFN response may promote susceptibility to infection by impairing the ability of the infected host cell to undergo early apoptosis and by allowing increased virus replication and, ultimately, cytolysis of infected cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Four hBDs (hBD-1 to -4) for airway mucosal defense have been identified in respiratory epithelial cells, but only hBD-2 and hBD-3 act against respiratory viruses (52, 73, 148, 267, 324).”
What the sources say
- Not checked yetcites [52] Doss, M., M. R. White, T. Tecle, D. Gantz, E. C. Crouch, G. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, and K. L. Hartshorn. 2009. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J. Immunol. 182:7878-7887. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [73] Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [148] Kota, S., A. Sabbah, T. H. Chang, R. Harnack, Y. Xiang, X. Meng, and S. Bose. 2008. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J. Biol. Chem. 283:22417-22429. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Data for humans show that increased exhaled nitric oxide after rhinovirus infection is correlated with reduced airway hyperresponsiveness in asthmatic patients, suggesting a beneficial effect of NO in virus-induced asthma exacerbations (42).”
What the sources say
- Not checked yetcites [42] de Gouw, H. W., K. Grunberg, R. Schot, A. C. Kroes, E. C. Dick, and P. J. Sterk. 1998. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur. Respir. J. 11:126-132. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Activation of NF-κB is common to many respiratory viruses, as demonstrated for rhinovirus (129, 203), RSV (24), and influenza virus (145).”
What the sources say
- Not checked yetcites [129] Johnston, S. L., A. Papi, P. J. Bates, J. G. Mastronarde, M. M. Monick, and G. W. Hunninghake. 1998. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J. Immunol. 160:6172-6181. [PubMed] [Google Scholar]
- Not checked yetcites [203] Papi, A., and S. L. Johnston. 1999. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J. Biol. Chem. 274:9707-9720. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [24] Bitko, V., A. Velazquez, L. Yang, Y. C. Yang, and S. Barik. 1997. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 232:369-378. [DOI] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The importance of nitric oxide production in antiviral defense of the airway epithelium is demonstrated by studies showing that increased virus (parainfluenza virus 3) replication in airway epithelial cells from CF patients is due at least partly to a lack of NOS-2 induction in response to virus and that NO donor or NOS-2 overexpression provides protection from virus infection (333, 334).”
What the sources say
- Not checked yetcites [333] Zheng, S., B. P. De, S. Choudhary, S. A. Comhair, T. Goggans, R. Slee, B. R. Williams, J. Pilewski, S. J. Haque, and S. C. Erzurum. 2003. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 18:619-630. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [334] Zheng, S., W. Xu, S. Bose, A. K. Banerjee, S. J. Haque, and S. C. Erzurum. 2004. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L374-L381. [DOI] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“NOS-2 is induced and NO production increased after infection with respiratory viruses (136, 191, 246, 287).”
What the sources say
- Not checked yetcites [136] Kao, Y. J., P. A. Piedra, G. L. Larsen, and G. N. Colasurdo. 2001. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 163:532-539. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [191] Murphy, A. W., T. A. Platts-Mills, M. Lobo, and F. Hayden. 1998. Respiratory nitric oxide levels in experimental human influenza. Chest 114:452-456. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [246] Sanders, S. P., J. Kim, K. R. Connolly, J. D. Porter, E. S. Siekierski, and D. Proud. 2001. Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 24:317-325. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Respiratory epithelial cells produce high levels of NO, as evidenced by detection of NO in exhaled breath and of NO reaction products (e.g., NO2− and NO3−) in bronchoalveolar lavage fluid from human lungs (77).”
What the sources say
- Not checked yetcites [77] Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-551. [DOI] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Bronchial biopsy specimens from subjects undergoing experimental rhinovirus infection show T-cell infiltration of the airway epithelium (69).”
What the sources say
- Not checked yetcites [69] Fraenkel, D. J., P. G. Bardin, G. Sanderson, F. Lampe, S. L. Johnston, and S. T. Holgate. 1995. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 151:879-886. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“RSV strains have also been documented to induce different patterns and severities of inflammatory responses (173, 174, 271).”
What the sources say
- Not checked yetcites [173] McNamara, P. S., B. F. Flanagan, C. A. Hart, and R. L. Smyth. 2005. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 191:1225-1232. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [174] McNamara, P. S., B. F. Flanagan, A. M. Selby, C. A. Hart, and R. L. Smyth. 2004. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur. Respir. J. 23:106-112. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [271] Smyth, R. L., K. J. Mobbs, U. O'Hea, D. Ashby, and C. A. Hart. 2002. Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr. Pulmonol. 33:339-346. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Airway epithelial cells have been shown to enhance cDC migration into the epithelium via MIP-3α/CCL20 production (232), and MIP-3α/CCL20 induction has been demonstrated in several viral infections, such as influenza virus infection (178, 308).”
What the sources say
- Not checked yetcites [232] Reibman, J., Y. Hsu, L. C. Chen, B. Bleck, and T. Gordon. 2003. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am. J. Respir. Cell Mol. Biol. 28:648-654. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [178] Message, S. D., and S. L. Johnston. 2004. Host defense function of the airway epithelium in health and disease: clinical background. J. Leukoc. Biol. 75:5-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [308] Wareing, M. D., A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar. 2004. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc. Biol. 76:886-895. [DOI] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, upon extrinsic and intrinsic stimuli such as viral infections, this complex regulatory mechanism is lost or shifts and proinflammatory immune responses are initiated (113, 301).”
What the sources say
- Not checked yetcites [113] Holt, P. G., D. H. Strickland, M. E. Wikstrom, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8:142-152. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [301] Wang, H., Z. Su, and J. Schwarze. 2009. Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax 64:283-290. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In contrast to cDCs, pDCs are not efficient antigen-presenting cells. Rather, their antiviral action is mediated by production of large amounts of IFN-α, which delivers a powerful innate response to limit viral replication.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Upon viral infection, pDCs are recruited rapidly from the bone marrow, and within several days, they form the majority of DCs in the lung (300).”
What the sources say
- Not checked yetcites [300] Wang, H., N. Peters, and J. Schwarze. 2006. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 177:6263-6270. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“For instance, studies of mice presensitized by recombinant vaccinia viruses showed that after RSV infection, animals exhibiting mainly Th2 cytokine responses developed enhanced disease with severe symptoms, whereas those with Th1 responses had reduced immunopathology and enhanced viral clearance (6).”
What the sources say
- Not checked yetcites [6] Alwan, W. H., W. J. Kozlowska, and P. J. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The appearance of antigen-specific effector T cells in the airways is observed around 6 to 7 days after infection with influenza and parainfluenza viruses (275).”
What the sources say
- Not checked yetcites [275] Swain, S. L., R. W. Dutton, and D. L. Woodland. 2004. T cell responses to influenza virus infection: effector and memory cells. Viral Immunol. 17:197-209. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, pandemic influenza viruses, including H5N1 avian influenza virus and the H1N1 2009 California influenza virus strain, have been associated with more severe inflammation than seasonal influenza virus strains, and it is believed that the magnitude of inflammation is a major contributing factor to disease severity (17, 200, 209, 283, 319).”
What the sources say
- Not checked yetcites [17] Bellani, G., L. Guerra, A. Pesenti, and C. Messa. 2010. Imaging of lung inflammation during severe influenza A: H1N1. Intensive Care Med. 36:717-718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [200] Osterlund, P., J. Pirhonen, N. Ikonen, E. Ronkko, M. Strengell, S. M. Makela, M. Broman, O. J. Hamming, R. Hartmann, T. Ziegler, and I. Julkunen. 2010. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J. Virol. 84:1414-1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [209] Perrone, L. A., J. K. Plowden, A. Garcia-Sastre, J. M. Katz, and T. M. Tumpey. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“NK cells also play an important role in the innate immune response against respiratory viruses, with their function being the elimination of a variety of target cells, including virus-infected cells, and the modulation of adaptive immunity toward an efficient antiviral response (22).”
What the sources say
- Not checked yetcites [22] Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Similarly, rhinovirus group C strains are thought to be associated with increased inflammation and morbidity compared with rhinovirus group A or B strains (10, 125).”
What the sources say
- Not checked yetcites [10] Arden, K. E., C. E. Faux, N. T. O'Neill, P. McErlean, A. Nitsche, S. B. Lambert, M. D. Nissen, T. P. Sloots, and I. M. Mackay. 2010. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J. Clin. Virol. 47:219-223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [125] Jin, Y., X. H. Yuan, Z. P. Xie, H. C. Gao, J. R. Song, R. F. Zhang, Z. Q. Xu, L. S. Zheng, Y. D. Hou, and Z. J. Duan. 2009. Prevalence and clinical characterization of a newly identified human rhinovirus C species in children with acute respiratory tract infections. J. Clin. Microbiol. 47:2895-2900. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Airway epithelial cells induce migration of Th1 cells into the mucosa via production of RANTES/CCL5 and IP-10/CXCL10 and that of Th2 cells via production of IL-1β (178).”
What the sources say
- Not checked yetcites [178] Message, S. D., and S. L. Johnston. 2004. Host defense function of the airway epithelium in health and disease: clinical background. J. Leukoc. Biol. 75:5-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Airway epithelial cells not only mediate innate immune responses but also regulate adaptive immune responses through interactions with DCs and T and B lymphocytes.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearIt may state two separate claims as one.
In the paper
“Interestingly, however, inhibition of neutrophil recruitment to the lung had no effect on virus clearance in a mouse model of influenza virus infection, suggesting only a minor role of neutrophils in this model of respiratory viral infection (309).”
What the sources say
- Not checked yetcites [309] Wareing, M. D., A. L. Shea, C. A. Inglis, P. B. Dias, and S. R. Sarawar. 2007. CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20:369-378. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Using in vitro culture systems, some differences between susceptibilities to rhinovirus infection have been noted, with bronchial epithelium generating higher viral loads and more expression of virus-inducible mediators than those in bronchial epithelial cells cultured in the same manner (163).”
What the sources say
- Not checked yetcites [163] Lopez-Souza, N., S. Favoreto, H. Wong, T. Ward, S. Yagi, D. Schnurr, W. E. Finkbeiner, G. M. Dolganov, J. H. Widdicombe, H. A. Boushey, and P. C. Avila. 2009. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123:1384-1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Whereas rhinovirus-induced cytotoxicity was shown in bronchial epithelial cells after rhinovirus infection (27)”
What the sources say
- Not checked yetcites [27] Bossios, A., S. Psarras, D. Gourgiotis, C. L. Skevaki, A. G. Constantopoulos, P. Saxoni-Papageorgiou, and N. G. Papadopoulos. 2005. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir. Res. 6:114. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Cytotoxicity upon infection with certain viruses may depend on the virus strain, infection conditions, and infected cell type and density (27).”
What the sources say
- Not checked yetcites [27] Bossios, A., S. Psarras, D. Gourgiotis, C. L. Skevaki, A. G. Constantopoulos, P. Saxoni-Papageorgiou, and N. G. Papadopoulos. 2005. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir. Res. 6:114. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We further discuss how vRTIs can lead to perturbed inflammatory responses and to increased mucus production, which will be detrimental rather than protective to the host.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, considering that the airway epithelium is the main site of viral infection, it is likely to contribute significantly to the type and magnitude of the inflammatory response.”
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
- Rests on an assumption: The airway epithelium is the main site of viral infection.
In the paper
“For instance, TGF-β increases airway wound repair through MMP-2 upregulation (154).”
What the sources say
- Not checked yetcites [154] Lechapt-Zalcman, E., V. Pruliere-Escabasse, D. Advenier, S. Galiacy, C. Charriere-Bertrand, A. Coste, A. Harf, M. P. d'Ortho, and E. Escudier. 2006. Transforming growth factor-beta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair? Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L1277-L1282. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Migrating basal airway epithelial cells repopulate damaged areas, proliferate, and differentiate until epithelial integrity has been restored (242).”
What the sources say
- Not checked yetcites [242] Sacco, O., M. Silvestri, F. Sabatini, R. Sale, A. C. Defilippi, and G. A. Rossi. 2004. Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr. Respir. Rev. 5(Suppl. A):S35-S40. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“MMPs play a crucial role in the remodeling of the matrix onto which cells migrate, and many pathways are involved in this process (294).”
What the sources say
- Not checked yetcites [294] Visse, R., and H. Nagase. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827-839. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Most viruses have efficient ways to inhibit IFN synthesis, to bind and inactivate secreted IFN molecules, to block IFN-activated signaling, or to disturb the action of IFN-induced antiviral proteins.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“It is currently believed that NS2 prevents RIG-I signaling by interfering with the RIG-I-MAVS interaction, therefore severely limiting signaling mediated by the critical interaction between the sensor RIG-I and its specific adaptor, MAVS (161).”
What the sources say
- Not checked yetcites [161] Ling, Z., K. C. Tran, and M. N. Teng. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83:3734-3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“V proteins may be expressed at high levels during the initial stages of infection and therefore limit IRF3 activation by binding IKK-ɛ and preventing IRF-3 activation, and hence IFN induction (165).”
What the sources say
- Not checked yetcites [165] Lu, L. L., M. Puri, C. M. Horvath, and G. C. Sen. 2008. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 283:14269-14276. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, they induce the production of proangiogenic molecules, including amphiregulin (a member of the epidermal growth factor [EGF] family) and vascular endothelial growth factor (VEGF), and therefore may lead to increased angiogenesis (156, 220).”
What the sources say
- Not checked yetcites [156] Leigh, R., W. Oyelusi, S. Wiehler, R. Koetzler, R. S. Zaheer, R. Newton, and D. Proud. 2008. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J. Allergy Clin. Immunol. 121:1238-1245. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [220] Psarras, S., E. Volonaki, C. L. Skevaki, M. Xatzipsalti, A. Bossios, H. Pratsinis, S. Tsigkos, D. Gourgiotis, A. G. Constantopoulos, A. Papapetropoulos, P. Saxoni-Papageorgiou, and N. G. Papadopoulos. 2006. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J. Allergy Clin. Immunol. 117:291-297. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The NS1 and NS2 proteins of RSV inhibit STAT-2 activation, thus blocking IFN-α/β function (161, 162).”
What the sources say
- Not checked yetcites [161] Ling, Z., K. C. Tran, and M. N. Teng. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83:3734-3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [162] Lo, M. S., R. M. Brazas, and M. J. Holtzman. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79:9315-9319. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A role for airway epithelial cells in contributing to the Th2 phenotype is possible, as they have receptors for and respond to IL-4, IL-13, and IL-25 (68, 115).”
What the sources say
- Not checked yetcites [68] Fort, M. M., J. Cheung, D. Yen, J. Li, S. M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, T. Muchamuel, S. D. Hurst, G. Zurawski, M. W. Leach, D. M. Gorman, and D. M. Rennick. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985-995. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [115] Hurst, S. D., T. Muchamuel, D. M. Gorman, J. M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T. T. Kung, J. K. Brieland, S. M. Zurawski, R. W. Chapman, G. Zurawski, and R. L. Coffman. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169:443-453. [DOI] [PubMed] [Google Scholar] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In allergic asthmatic subjects, Th1 responses to rhinovirus are downregulated, as indicated by lower levels of IL-12 and IFN-γ, whereas Th2 responses are increased, with higher levels of IL-4, IL-5, and IL-13 (179).”
What the sources say
- Not checked yetcites [179] Message, S. D., V. Laza-Stanca, P. Mallia, H. L. Parker, J. Zhu, T. Kebadze, M. Contoli, G. Sanderson, O. M. Kon, A. Papi, P. K. Jeffery, L. A. Stanciu, and S. L. Johnston. 2008. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. U. S. A. 105:13562-13567. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, RSV and rhinovirus can lead to induction of the pro-Th2 cytokine TSLP, suggesting a direct link between viral infection of the epithelium and an altered immune response toward a Th2 pattern (4, 157, 264).”
What the sources say
- Not checked yetcites [4] Allakhverdi, Z., M. R. Comeau, H. K. Jessup, B. R. Yoon, A. Brewer, S. Chartier, N. Paquette, S. F. Ziegler, M. Sarfati, and G. Delespesse. 2007. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204:253-258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [157] Lemanske, R. F., Jr., D. J. Jackson, R. E. Gangnon, M. D. Evans, Z. Li, P. A. Shult, C. J. Kirk, E. Reisdorf, K. A. Roberg, E. L. Anderson, K. T. Carlson-Dakes, K. J. Adler, S. Gilbertson-White, T. E. Pappas, D. F. Dasilva, C. J. Tisler, and J. E. Gern. 2005. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J. Allergy Clin. Immunol. 116:571-577. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [264] Sigurs, N., R. Bjarnason, F. Sigurbergsson, and B. Kjellman. 2000. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:1501-1507. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This is illustrated by studies showing that influenza virus infection results in decreased tracheal mucociliary velocity and clearance of S. pneumoniae (172, 213).”
What the sources say
- Not checked yetcites [172] McCullers, J. A., A. R. Iverson, R. McKeon, and P. J. Murray. 2008. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand. J. Infect. Dis. 40:11-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [213] Pittet, L. A., L. Hall-Stoodley, M. R. Rutkowski, and A. G. Harmsen. 2010. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 42:450-460. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“For instance, rhinoviruses disrupt airway epithelial barrier functions and promote the paracellular migration of bacteria such as H. influenzae (244).”
What the sources say
- Not checked yetcites [244] Sajjan, U., Q. Wang, Y. Zhao, D. C. Gruenert, and M. B. Hershenson. 2008. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am. J. Respir. Crit. Care Med. 178:1271-1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition, perturbation of the epithelial barrier upon virus infection may increase paracellular permeability and facilitate translocation of bacteria and their soluble products into the submucosa.”
What the sources say
- Not checked yetcites [244] Sajjan, U., Q. Wang, Y. Zhao, D. C. Gruenert, and M. B. Hershenson. 2008. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am. J. Respir. Crit. Care Med. 178:1271-1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Mechanisms involved in ciliostasis are poorly understood but could be mediated by ion alterations during viral attachment and replication, by direct damage to the ciliary system, or by damage through the induction of NO, cyclic AMP, calmodulin, and inositol 1,4,5-triphosphate (InP3) production, which alters baseline ciliary beat frequency (33) or modulates hfh4 and mdnh5 gene expression, resulting”
What the sources say
- Not checked yetcites [33] Chilvers, M. A., and C. O'Callaghan. 2000. Local mucociliary defence mechanisms. Paediatr. Respir. Rev. 1:27-34. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [169] Mall, M. A. 2008. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J. Aerosol Med. Pulm. Drug Deliv. 21:13-24. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It also increases the expression of ICAM-1, which serves as a receptor both for itself and for H. influenzae (11, 316).”
What the sources say
- Not checked yetcites [11] Avadhanula, V., C. A. Rodriguez, J. P. Devincenzo, Y. Wang, R. J. Webby, G. C. Ulett, and E. E. Adderson. 2006. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol. 80:1629-1636. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [316] Whiteman, S. C., A. Bianco, R. A. Knight, and M. A. Spiteri. 2003. Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J. Biol. Chem. 278:11954-11961. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“For instance, whereas RSV upregulates cellular receptors such as ICAM-1 and CEACAM-1, leading to an increase of bacterial adherence, influenza virus has no effect on the expression of these receptors (11).”
What the sources say
- Not checked yetcites [11] Avadhanula, V., C. A. Rodriguez, J. P. Devincenzo, Y. Wang, R. J. Webby, G. C. Ulett, and E. E. Adderson. 2006. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol. 80:1629-1636. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Increased bacterial adherence facilitates biofilm formation and could represent a critical step in permanent airway colonization by P. aeruginosa in cystic fibrosis patients (98).”
What the sources say
- Not checked yetcites [98] Hassett, D. J., T. R. Korfhagen, R. T. Irvin, M. J. Schurr, K. Sauer, G. W. Lau, M. D. Sutton, H. Yu, and N. Hoiby. 2010. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin. Ther. Targets 14:117-130. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, virus-induced cell death may expose new receptors for bacterial adherence or impair mechanical removal of attached pathogens (30, 41, 96).”
What the sources say
- Not checked yetcites [30] Bragonzi, A., E. Copreni, S. de Bentzmann, M. Ulrich, and M. Conese. 2004. Airway epithelial cell-pathogen interactions. J. Cyst. Fibros. 3(Suppl. 2):197-201. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [41] de Bentzmann, S., C. Plotkowski, and E. Puchelle. 1996. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am. J. Respir. Crit. Care Med. 154:S155-S162. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [96] Hament, J. M., J. L. Kimpen, A. Fleer, and T. F. Wolfs. 1999. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26:189-195. [DOI] [PubMed] [Google Scholar]
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Mechanisms responsible for the increased adherence to respiratory epithelial cells differ between viruses and also between cell types.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For example, steroids are well established as suppressors of viral (56, 268, 296) and bacterial (100) inflammation and mucin production and may modulate epithelial damage, injury, and repair.”
What the sources say
- Not checked yetcites [56] Edwards, M. R., M. W. Johnson, and S. L. Johnston. 2006. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 34:616-624. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [268] Skevaki, C. L., I. Christodoulou, I. S. Spyridaki, I. Tiniakou, V. Georgiou, P. Xepapadaki, D. A. Kafetzis, and N. G. Papadopoulos. 2009. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin. Exp. Allergy 39:1700-1710. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [296] Volonaki, E., S. Psarras, P. Xepapadaki, D. Psomali, D. Gourgiotis, and N. G. Papadopoulos. 2006. Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors. Clin. Exp. Allergy 36:1268-1273. [DOI] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Impairment of TLR4 and TLR5 has been demonstrated after influenza virus infection, leading to reduced neutrophil recruitment and increased P. aeruginosa and S. pneumoniae adherence in airway epithelial cells (46).”
What the sources say
- Not checked yetcites [46] Didierlaurent, A., J. Goulding, S. Patel, R. Snelgrove, L. Low, M. Bebien, T. Lawrence, L. S. van Rijt, B. N. Lambrecht, J. C. Sirard, and T. Hussell. 2008. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205:323-329. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“They lead to more than 400,000 hospitalizations per year among children in the United States and are therefore a major burden on the health care system (105, 180, 194).”
What the sources say
- Not checked yetcites [105] Henrickson, K. J., S. Hoover, K. S. Kehl, and W. Hua. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [180] Mizgerd, J. P. 2006. Lung infection—a public health priority. PLoS Med. 3:e76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [194] Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, A. Chandran, E. Theodoratou, A. Sutanto, E. R. Sedyaningsih, M. Ngama, P. K. Munywoki, C. Kartasasmita, E. A. Simoes, I. Rudan, M. W. Weber, and H. Campbell. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545-1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“A recent study demonstrated effectiveness of the ketomacrolide telithromycin in asthma exacerbations (128).”
What the sources say
- Not checked yetcites [128] Johnston, S. L., F. Blasi, P. N. Black, R. J. Martin, D. J. Farrell, and R. B. Nieman. 2006. The effect of telithromycin in acute exacerbations of asthma. N. Engl. J. Med. 354:1589-1600. [DOI] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“a recent study found no protective effect of the above in a trial of post-RSV bronchiolitis in children (23).”
What the sources say
- Not checked yetcites [23] Bisgaard, H., A. Flores-Nunez, A. Goh, P. Azimi, A. Halkas, M. P. Malice, J. L. Marchal, S. B. Dass, T. F. Reiss, and B. A. Knorr. 2008. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am. J. Respir. Crit. Care Med. 178:854-860. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“By use of in vitro culture systems, azithromycin was able to augment rhinovirus-induced IFNs and their inducible genes and to decrease virus replication (81).”
What the sources say
- Not checked yetcites [81] Gielen, V., S. L. Johnston, and M. R. Edwards. 2010. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur. Respir. J. 36:646-654. [DOI] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“vRTIs are an important cause of morbidity and, in some cases, mortality.”
What the sources say
- Not checked yetcites [105] Henrickson, K. J., S. Hoover, K. S. Kehl, and W. Hua. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [180] Mizgerd, J. P. 2006. Lung infection—a public health priority. PLoS Med. 3:e76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [194] Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, A. Chandran, E. Theodoratou, A. Sutanto, E. R. Sedyaningsih, M. Ngama, P. K. Munywoki, C. Kartasasmita, E. A. Simoes, I. Rudan, M. W. Weber, and H. Campbell. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545-1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“While a recent study demonstrated that children admitted to hospital with asthma-related symptoms were less likely to have used therapies, including leukotriene receptor antagonists (127)”
What the sources say
- Not checked yetcites [127] Johnston, N. W., S. L. Johnston, J. M. Duncan, J. M. Greene, T. Kebadze, P. K. Keith, M. Roy, S. Waserman, and M. R. Sears. 2005. The September epidemic of asthma exacerbations in children: a search for etiology. J. Allergy Clin. Immunol. 115:132-138. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, respiratory viruses have evolved strategies to subvert epithelial defense mechanisms and can lead to complications such as loss of epithelial integrity, perturbed inflammatory responses, increased mucus production, and secondary bacterial infections.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
The paper relies on this without support.
The airway epithelium is the main site of viral infection.
“However, considering that the airway epithelium is the main site of viral infection, it is likely to contribute significantly to the type and magnitude of the inflammatory response.”
The paper relies on this without support.
The physiochemical characteristics of the upper (nasal) and lower (bronchial) epithelia are very similar.
“The general consensus is that the physiochemical characteristics of the upper (nasal) and lower (bronchial) epithelia are very similar”
The paper relies on this without support.
The airway epithelium plays an important role as a protective physical and functional barrier between the external environment and underlying tissues and as a central element in the initiation and regulation of innate and adaptive immune responses in the lung.
“The airway epithelium plays an important role as a protective physical and functional barrier between the external environment and underlying tissues and as a central element in the initiation and regulation of innate and adaptive immune responses in the lung.”
The paper relies on this without support.
Airway epithelial cells are the principal hosts for respiratory viruses.
“Airway epithelial cells are the principal hosts for respiratory viruses.”
The paper relies on this without support.
Apoptosis acts as a protective mechanism to limit replication and spread of the virus to other cells, but exaggerated apoptosis can lead to a loss of integrity and protection of the epithelium, with detrimental consequences.
“Apoptosis acts as a protective mechanism to limit replication and spread of the virus to other cells, but exaggerated apoptosis can lead to a loss of integrity and protection of the epithelium, with detrimental consequences.”
The paper relies on this without support.
Epithelial repair initiates quickly after injury.
“Epithelial repair initiates quickly after injury.”
The paper relies on this without support.
Mucus contains many components that bind bacteria.
“Mucus contains many components that bind bacteria.”
The paper relies on this without support.
Most respiratory viral infections are self-limited and associated with minor morbidity.
“Fortunately, most respiratory viral infections are self-limited and associated with minor morbidity.”
The paper relies on this without support.
A frequent point of interference by viruses is the Jak-STAT signaling pathway, used by IFNs to induce transcription of antiviral genes.
“A frequent point of interference by viruses is the Jak-STAT signaling pathway, used by IFNs to induce transcription of antiviral genes.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, mucus production in the respiratory tract is increased to facilitate viral clearance during infections. However, excessive mucus production can lead to airway obstruction by impeding mucociliary clearance (125).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Bronchial cells are compared with bronchial cells instead of nasal cells
MinorThe text says bronchial epithelium produced higher viral loads than bronchial epithelial cells cultured the same way. The cited reference instead identifies the comparison as bronchial versus nasal cells.
“bronchial epithelium generating higher viral loads and more expression of virus-inducible mediators than those in bronchial epithelial cells cultured in the same manner (163).”
“163.Lopez-Souza, N., S. Favoreto, H. Wong, T. Ward, S. Yagi, D. Schnurr, W. E. Finkbeiner, G. M. Dolganov, J. H. Widdicombe, H. A. Boushey, and P. C. Avila. 2009. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects.”
Table 2 calls non-human specimens human
MinorTable 2 is headed as a list of studies using human respiratory epithelial cells, but its first entry uses murine tracheal explants; other entries also list animal tissues or cells.
“Studies on bacterial adherence to human respiratory epithelial cells during viral infection”
“2010 ( 213 ) Influenza virus S. pneumoniae Murine tracheal explants”
HPIV-3 is expanded as metapneumovirus rather than parainfluenza virus
MinorTable 2's footnote expands HPIV-3 as human metapneumovirus type 3, whereas the paper's cited reference uses the name human parainfluenza virus type 3.
“RV, rhinovirus; HPIV-3, human metapneumovirus type 3.”
“332.Zhang, L., A. Bukreyev, C. I. Thompson, B. Watson, M. E. Peeples, P. L. Collins, and R. J. Pickles. 2005. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.”
TLR7 is assigned two different RNA ligands
MinorThe first passage says TLR7 recognizes double-stranded RNA, while the later passage says TLR7 recognizes single-stranded RNA.
“TLR7, TLR8, and TLR9 recognize double-stranded RNA (dsRNA), single-stranded RNA (ssRNA), and CpG DNA, respectively (141).”
“pDCs typically express TLR7 and TLR9, recognizing single-stranded RNA and viral DNA”
Table 2 misidentifies the bacterium in its 1982 study
MinorThe table lists S. pneumoniae for reference 131, but that reference's title identifies type 1a group B streptococci.
“1982 ( 131 ) Influenza virus S. pneumoniae Mouse tracheal tissue”
“131.Jones, W. T., and J. H. Menna. 1982. Influenza type A virus-mediated adherence of type 1a group B streptococci to mouse tracheal tissue in vivo.”
Citations
Cites
Items 201–341 of 341
Garbino, J., Crespo, S., Aubert, J., Rochat, T., Ninet, B., Deffernez, C., Wunderli, W., Pache, J., Soccal, P. M., & Kaiser, L. (2006) · Clinical Infectious Diseases · doi:10.1086/507898 · Cited by 135
Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae.
Håkansson, A., Kidd, A., Wadell, G., Sabharwal, H., & Svanborg, C. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2707-2714.1994 · Cited by 134
Severe Pneumonia Due to Adenovirus Serotype 14: A New Respiratory Threat?
Louie, J. K., Kajon, A. E., Holodniy, M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525261 · Cited by 132
VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION
Basler, C. F., & García‐Sastre, A. (2002) · International Reviews of Immunology · doi:10.1080/08830180213277 · Cited by 130
Woo, P. C. Y., Tung, E. T. K., Chan, K., Lau, C. C. Y., Lau, S. K. P., & Yuen, K. (2009) · The Journal of Infectious Diseases · doi:10.1086/649785 · Cited by 130
Lukens, M. V., Kruijsen, D., Coenjaerts, F. E. J., Kimpen, J. L. L., & van Bleek, G. M. (2009) · Journal of Virology · doi:10.1128/jvi.00452-09 · Cited by 127
Hassett, D. J., Korfhagen, T. R., Irvin, R. T., Schurr, M. J., Sauer, K., Lau, G. W., Sutton, M. D., Yu, H. D., & Høiby, N. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903454988 · Cited by 126
Zheng, S., De, B. P., Choudhary, S., Comhair, S. A. A., Goggans, T., Slee, R., Williams, B. R. G., Pilewski, J., Haque, S. J., & Erzurum, S. C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00114-6 · Cited by 125
Respiratory Virus Infection of Monolayer Cultures of Human Nasal Epithelial Cells
Winther, B., Gwaltney, J. M., & Hendley, J. O. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.839 · Cited by 124
Emerging respiratory agents: New viruses for old diseases?
Sloots, T. P., Whiley, D. M., Lambert, S. B., & Nissen, M. D. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.03.002 · Cited by 124
Shotgun proteomic analysis of human‐induced sputum
Nicholas, B., Skipp, P. J. S., Mould, R. F., Rennard, S. I., Davies, D. E., O’Connor, C. D., & Djukanović, R. (2006) · PROTEOMICS · doi:10.1002/pmic.200600011 · Cited by 122
Qiu, Y., Zhu, J., Bandi, V., Guntupalli, K. K., & Jeffery, P. K. (2007) · Thorax · doi:10.1136/thx.2006.066670 · Cited by 122
HORNSLETH, A., KLUG, B., NIR, M., JOHANSEN, J., HANSEN, K. S., CHRISTENSEN, L. S., & LARSEN, L. B. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199812000-00003 · Cited by 119
Etiology of asthma exacerbations
Sykes, A., & Johnston, S. L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.08.017 · Cited by 119
Human rhinoviruses: The cold wars resume
Mackay, I. M. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.04.002 · Cited by 119
Respiratory Syncytial Virus in Allergic Lung Inflammation Increases Muc5ac and Gob-5
Hashimoto, K., Graham, B. S., Ho, S. B., Adler, K. B., Collins, R. D., Olson, S. J., Zhou, W., Suzutani, T., Jones, P. W., Goleniewska, K., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-030oc · Cited by 118
Epithelial cells and fibroblasts: structural repair and remodelling in the airways
Sacco, O., Silvestri, M., Sabatini, F., Sale, R., Defilippi, A., & Rossi, G. A. (2004) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0542(04)90008-5 · Cited by 115
Local mucociliary defence mechanisms
Chilvers, M. A., & O’Callaghan, C. (2000) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2000.0009 · Cited by 115
RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells
van Ewijk, B. E., Wolfs, T. F. W., Aerts, P. C., Van Kessel, K. P. M., Fleer, A., Kimpen, J. L. L., & Van Der Ent, C. K. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332d1c · Cited by 113
The role of IL-12, IL-23 and IFN-γ in immunity to viruses
Novelli, F., & Casanova, J. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.009 · Cited by 113
Respiratory Consequences of Rhinovirus Infection
Greenberg, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.3.278 · Cited by 112
Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection.
Sanford, B. A., Shelokov, A., & Ramsay, M. A. (1978) · Journal of Infectious Diseases · doi:10.1093/infdis/137.2.176 · Cited by 111
Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis
McNamara, P. S., Flanagan, B., Selby, A. M., Hart, C. A., & Smyth, R. L. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00048103 · Cited by 111
Holt, P. G., Degebrodt, A., O'Leary, C., Krska, K., & Plozza, T. M. (1985) · PubMed Central · Cited by 110
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations
De Serres, G., Lampron, N., La Forge, J., Rouleau, I., Bourbeau, J., Weiss, K., Barret, B., & Boivin, G. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.07.010 · Cited by 108
Edwards, M. R., Johnson, M. W., & Johnston, S. L. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0385oc · Cited by 107
Self-citationReceptors in the Pseudomonas Aeruginosa Adherence to Injured and Repairing Airway Epithelium
de Bentzmann, S., Plotkowski, C., & Puchelle, É. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.4_pt_2.s155 · Cited by 106
Hament, J.-M., Aerts, P. C., Fleer, A., van Dijk, H., Harmsen, T., Kimpen, J. L. L., & Wolfs, T. F. W. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000188699.55279.1b · Cited by 106
Boukhvalova, M. S., Prince, G. A., Soroush, L., Harrigan, D. C., Vogel, S. N., & Blanco, J. C. G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.064 · Cited by 105
Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide.
Folkerts, G., van der Linde, H. J., & Nijkamp, F. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117649 · Cited by 104
Uetani, K., Der, S. D., Zamanian-Daryoush, M., de la Motte, C., Lieberman, B. Y., Williams, B. R. G., & Erzurum, S. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.988 · Cited by 100
Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009.
(2009) · PubMed · Cited by 99
Jiang, Z., Nagata, N., Molina, E., Bakaletz, L. O., Hawkins, H. K., & Patel, J. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.187-192.1999 · Cited by 98
Type III IFNs: New layers of complexity in innate antiviral immunity
Ank, N., & Paludan, S. R. (2009) · BioFactors · doi:10.1002/biof.19 · Cited by 98
Ostler, T., Hussell, T., Surh, C. D., Openshaw, P., & Ehl, S. R. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9 · Cited by 96
Lu, L. L., Puri, M., Horvath, C. M., & Sen, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710089200 · Cited by 96
Rhinovirus and the initiation of asthma
Gern, J. E. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32831f8f1b · Cited by 95
Simon, H., Seelbach, H., Ehmann, R., & Schmitz, M. (2003) · Allergy · doi:10.1046/j.1398-9995.2003.00424.x · Cited by 94
Vascular endothelial growth factor–mediated induction of angiogenesis by human rhinoviruses
Psarras, S., Volonaki, E., Skevaki, C. L., Xatzipsalti, M., Bossios, A., Pratsinis, H., Tsigkos, S., Gourgiotis, D., Constantopoulos, A. G., Papapetropoulos, A., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.005 · Cited by 94
Respiratory Nitric Oxide Levels in Experimental Human Influenza
Murphy, A. W., Platts‐Mills, T. A. E., Lobo, M., & Hayden, F. G. (1998) · CHEST Journal · doi:10.1378/chest.114.2.452 · Cited by 94
Nagarkar, D. R., Wang, Q., Shim, J., Zhao, Y., Tsai, W. C., Lukacs, N. W., Sajjan, U. S., & Hershenson, M. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900298 · Cited by 93
Smit, J. J., Lindell, D. M., Boon, L., Kool, M., Lambrecht, B. N., & Lukacs, N. W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001720 · Cited by 93
The Host Response and Molecular Pathogenesis Associated with Respiratory Syncytial Virus Infection
Oshansky, C. M., Zhang, W., Moore, E., & Tripp, R. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.1 · Cited by 93
Respiratory syncytial virus bronchiolitis: Disease severity, interleukin‐8, and virus genotype*
Smyth, R. L., Mobbs, K. J., O'Hea, U., et al. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10080 · Cited by 92
Avadhanula, V., Wang, Y., Portner, A., & Adderson, E. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47086-0 · Cited by 91
Sano, H. I., Nagai, K., Tsutsumi, H., & Kuroki, Y. (2003) · European Journal of Immunology · doi:10.1002/eji.200324218 · Cited by 90
Papadopoulos, N. G., Xepapadaki, P. V., Mallia, P., Brusselle, G., Watelet, J. B., Xatzipsalti, M., Foteinos, G., van Drunen, C. M., Fokkens, W. J., D’Ambrosio, C., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01341.x · Cited by 90
Toll like receptors and viruses
Finberg, R. W., Wang, J. P., & Kurt‐Jones, E. A. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.525 · Cited by 90
Rate, A., Upham, J. W., Bosco, A., McKenna, K. L., & Holt, P. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.72 · Cited by 88
Role of MyD88 and TLR9 in the Innate Immune Response Elicited by Serotype 5 Adenoviral Vectors
Yamaguchi, T., Kawabata, K., Koizumi, N., Sakurai, F., Kaneda‐Nakashima, K., Sakurai, H., Sasaki, T., Okada, N., Yamanishi, K., & Mizuguchi, H. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.016 · Cited by 87
Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus
Wang, S.-Z., Xu, H., Wraith, A., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12030612 · Cited by 87
Adenovirus infections and lung disease
HAYASHI, S., & Hogg, J. C. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.014 · Cited by 86
Wareing, M. D., Shea, A. L., Inglis, C. A., Dias, P. B., & Sarawar, S. R. (2007) · Viral Immunology · doi:10.1089/vim.2006.0101 · Cited by 82
Effect of Salmeterol on Pseudomonas Aeruginosa Infection of Respiratory Mucosa
Dowling, R., Rayner, C. F., Rutman, A., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.1.9001332 · Cited by 81
Cell Adhesion Molecules and the Bronchial Epithelium
Roche, W. R., Montefort, S., Baker, J. E., et al. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.6_pt_2.s79 · Cited by 81
Jacques, J., Moret, H., Minette, D., Lévêque, N., Jovenin, N., Deslée, G., Lebargy, F., Motte, J., & Andréoletti, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01414-07 · Cited by 81
Whiteman, S. C., Bianco, A., Knight, R. A., & Spiteri, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205329200 · Cited by 80
Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells
Bossios, A., Psarras, S., Gourgiotis, D., Skevaki, C. L., Constantopoulos, A. G., Saxoni-Papageorgiou, P., & Papadopoulos, N. G. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-114 · Cited by 79
Patel, J., Faden, H., Sharma, S., & Ogra, P. L. (1992) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/0165-5876(92)90075-z · Cited by 77
Mucin Overproduction in Chronic Inflammatory Lung Disease
Hauber, H., Foley, S. C., & Hamid, Q. A. (2006) · Canadian Respiratory Journal · doi:10.1155/2006/901417 · Cited by 77
Role of oxidants in influenza virus-induced gene expression
Knobil, K., Choi, A. M. K., Weigand, G. W., & Jacoby, D. B. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.274.1.l134 · Cited by 77
Toll-like receptors in the respiratory system: Their roles in inflammation
Iwamura, C., & Nakayama, T. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0003-0 · Cited by 76
KAO, Y. J., Piedra, P. A., Larsen, G. L., & Colasurdo, G. N. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.9912068 · Cited by 76
Toll-like receptor expression and function in airway epithelial cells.
Greene, C. M., & McElvaney, N. G. (2005) · PubMed · Cited by 75
Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro
Dowling, R., Johnson, M. W., COLE, P. J., & Wilson, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11010086 · Cited by 75
Effects of TNF‐α, IFN‐γ and IL-β on normal human bronchial epithelial cells
Kampf, C., Relova, A. J., Sandler, S., et al. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a15.x · Cited by 73
Development of dendritic cell system.
LiWu, & AleksandarDakic (2004) · PubMed · Cited by 72
Sanders, S. P., Siekierski, E. S., Richards, S. M., Porter, J. D., Imani, F., & Proud, D. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112028 · Cited by 72
Respiratory viral infections in adults
Greenberg, S. B. (2002) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200205000-00009 · Cited by 71
Singh, D., McCann, K. L., & Imani, F. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2007 · Cited by 70
Innate immune response to viral infection of the lungs
See, H. V., & Wark, P. A. B. (2008) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2008.04.001 · Cited by 70
Lechapt, E., Prulière-Escabasse, V., Advenier, D., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00149.2005 · Cited by 70
Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium
Zheng, S., Xu, W., Bose, S., Banerjee, A. K., Haque, S. J., & ERZURUM, S. C. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00039.2004 · Cited by 69
Human bocavirus: clinical significance and implications
Kahn, J. S. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282f3f518 · Cited by 67
Intercellular Junctional Proteins as Receptors and Barriers to Virus Infection and Spread
Bergelson, J. M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.009 · Cited by 67
Saadi, A. T., Blackwell, C. C., Raza, M. W., James, V. S., Stewart, J., Elton, R. A., & Weir, D. M. (1993) · Epidemiology and Infection · doi:10.1017/s0950268800050937 · Cited by 67
Mallia, P., Contoli, M., Caramori, G., Pandit, A., Johnston, S. L., & Papi, A. A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313777 · Cited by 67
Toll Like Receptors 4 and 2 Expression in the Bronchial Mucosa of Patients with Cystic Fibrosis
Hauber, H.-P., Tulic, M. K., Tsicopoulos, A., Wallaert, B., Olivenstein, R., Daigneault, P., & Hamid, Q. (2005) · Canadian Respiratory Journal · doi:10.1155/2005/648984 · Cited by 67
Skevaki, C. L., Christodoulou, I., Spyridaki, I. S., Tiniakou, I., Georgiou, V., Xepapadaki, P., Kafetzis, D. A., & Papadopoulos, N. G. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03307.x · Cited by 67
Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
Rogers, D. F. (2000) · PubMed · Cited by 66
Jamaluddin, M., Garofalo, R., Ogra, P. L., & Brasier, A. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1554-1563.1996 · Cited by 66 · cited 2×
“Activated STAT1/2 forms a complex with IRF-9 (also called ISGF3) which translocates to the nucleus and induces IFN-stimulated genes (ISGs), leading to the production of the proapoptotic p53 protein (277, 326) and of several antiviral proteins (9, 35, 159, 245).”
Jin, Y., Yuan, X., Xie, Z., Gao, H., Song, J., Zhang, R., Xu, Z., Zheng, L., Hou, Y., & Duan, Z.-J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00745-09 · Cited by 65
T Cell Responses to Influenza Virus Infection: Effector and Memory Cells
Swain, S. L., Dutton, R. W., & Woodland, D. L. (2004) · Viral Immunology · doi:10.1089/0882824041310577 · Cited by 63
Mukherjee, A., Morosky, S. A., Shen, L., Weber, C. R., Turner, J. R., Kim, K. S., Wang, T., & Coyne, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807547200 · Cited by 62
Upper airway defence mechanisms
Fokkens, W. J., & Scheeren, R. A. (2000) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2000.0073 · Cited by 60
Airway Epithelial IL-15 Transforms Monocytes into Dendritic Cells
Regamey, N., Obregon, C., Ferrari‐Lacraz, S., van Leer‐Buter, C., Chanson, M., Nicod, L. P., & Geiser, T. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0235oc · Cited by 59
Self-citationBinding of Haemophilus influenzae to purified mucins from the human respiratory tract
Davies, J. R., Carlstedt, I., Nilsson, A.-K., Håkansson, A., Sabharwal, H., van Alphen, L., van Ham, S. M., & Svanborg, C. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2485-2492.1995 · Cited by 59
Jain, R., & Goldman, R. D. (2009) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181c3c8f8 · Cited by 55
Emerging role of dendritic cells in respiratory viral infection
Grayson, M. H., & Holtzman, M. J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0212-3 · Cited by 55
Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment
Xatzipsalti, M., Psarros, F., Konstantinou, G. Ν., Gaga, M., Gourgiotis, D., Saxoni‐Papageorgiou, P., & Papadopoulos, N. G. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02906.x · Cited by 54
Sanders, S. P., Kim, J., Ryan Connolly, K., Porter, J. D., Siekierski, E. S., & Proud, D. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.3.4131 · Cited by 53
Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation
Hiemstra, P. S. (2001) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2001.0165 · Cited by 53
Molecular aspects of the epithelial phenotype
Davies, J. A., & Garrod, D. R. (1997) · BioEssays · doi:10.1002/bies.950190810 · Cited by 52
Regulation of Antiviral Innate Immune Responses by RIG-I Family of RNA Helicases
Onomoto, K., Yoneyama, M., & Fujita, T. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_10 · Cited by 51
Human Metapneumovirus Inhibits IFN-α Signaling through Inhibition of STAT1 Phosphorylation
Dinwiddie, D. L., & Harrod, K. S. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0285oc · Cited by 51
Arden, K. E., Faux, C. E., O'Neill, N. T., et al. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.01.001 · Cited by 50
Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa
Reddy, M. S. (1992) · Infection and Immunity · doi:10.1128/iai.60.4.1530-1535.1992 · Cited by 48
The Immune Response to Respiratory Syncytial Virus Infection: Friend or Foe?
Welliver, R. C. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8033-2 · Cited by 46
Role of Human Polyomaviruses in Respiratory Tract Disease in Young Children
Wattier, R. L., Vázquez, M., Weibel, C., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1411.080394 · Cited by 46
Isolation of human β-defensin-4 in lung tissue and its increase in lower respiratory tract infection
Yanagi, S., Ashitani, J.-I., Ishimoto, H., et al. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-130 · Cited by 45
Bacterial Adherence to the Upper Respiratory Tract of Ferrets Infected with Influenza A Virus
Sanford, B. A., & Ramsay, M. A. (1987) · Experimental Biology and Medicine · doi:10.3181/00379727-185-42525 · Cited by 45
Volonaki, E., Psarras, S., Xepapadaki, P., Psomali, D., Gourgiotis, D., & Papadopoulos, N. G. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02566.x · Cited by 44
Chronic bronchitis: The role of viruses
Hogg, J. C. (2000) · Seminars in Respiratory Infections · doi:10.1053/srin.2000.0150032 · Cited by 43
Viral Evasion of the Interferon System
Gale, M., & Sen, G. C. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0078 · Cited by 43
Influenza A virus‐induced caspase‐3 cleaves the histone deacetylase 6 in infected epithelial cells
Husain, M., & Harrod, K. S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.005 · Cited by 42
Saadi, A. T., Blackwell, C. C., Essery, S. D., Raza, M., Ahmer, O. R. E., MacKenzie, D. A. C., James, V. S., Weir, D. M., OGILVIE, M. M., Elton, R. A., et al. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1996.tb00111.x · Cited by 42
Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation
Wang, H., Su, Z., & Schwarze, J. (2009) · Thorax · doi:10.1136/thx.2007.094870 · Cited by 39
Model for studying bacterial adherence to epithelial cells infected with viruses.
Selinger, D. S., Reed, W. P., & McLaren, L. C. (1981) · Infection and Immunity · doi:10.1128/iai.32.2.941-944.1981 · Cited by 38
Combined airways: impact of upper airway on lower airway
Fasano, M. B. (2010) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328334aa0e · Cited by 38
Weinberg, G. A. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000218037.83110.c4 · Cited by 38
Bacterial biofilm in upper respiratory tract infections
Morris, D. P. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0030-3 · Cited by 37
Mccullers, J. A., Iverson, A. R., Mckeon, R., & Murray, P. J. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701477568 · Cited by 36
Fibrinogen-mediated adherence of group A Streptococcus to influenza A virus-infected cell cultures
Sanford, B. A., Davison, V. E., & Ramsay, M. A. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.513-520.1982 · Cited by 33
Integrative genomic analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and -λ3
Wei, W. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000408 · Cited by 33
New treatment regimes for virus-induced exacerbations of asthma
Edwards, M. R., Kebadze, T., Johnson, M. W., & Johnston, S. L. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.09.005 · Cited by 30
Self-citationEffect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice
Li, W., & Shen, H. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200701010-00002 · Cited by 29
Viral infections and allergies
Xepapadaki, P. V., & Papadopoulos, N. G. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.03.008 · Cited by 29
Wang, J. H., Kwon, H. J., & Jang, Y. J. (2009) · The Laryngoscope · doi:10.1002/lary.20574 · Cited by 29
The role of nitric oxide synthases in lung inflammation.
Esposito, E., & Cuzzocrea, S. (2007) · PubMed · Cited by 28
Koetzler, R., Zaheer, R. S., Newton, R. C., & Proud, D. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.041 · Cited by 28
Young, D. F., Carlos, T. S., Hagmaier, K., Fan, L., & Randall, R. E. (2007) · Virology · doi:10.1016/j.virol.2007.03.061 · Cited by 28
Effect of Dexamethasone and ACC on Bacteria-Induced Mucin Expression in Human Airway Mucosa
Hauber, H., Goldmann, T., Vollmer, E., Wollenberg, B., & Zabel, P. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0404oc · Cited by 28
Yu, D., Wei, L., Zhengxiu, L., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03147.x · Cited by 27
Local Production of Inflammatory Mediators During Childhood Parainfluenza Virus Infection
El Feghaly, R. E., McGann, L., Bonville, C. A., Branigan, P. J., Suryadevera, M., Rosenberg, H. F., & Domachowske, J. B. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181d5da2a · Cited by 27
Molecular Mechanisms of Respiratory Virus-Induced Asthma and COPD Exacerbations and Pneumonia
Adcock, I. M., Papi, A. A., Contoli, M., et al. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935159 · Cited by 26
Pathophysiology of viral-induced exacerbations of COPD.
Potena, A., Caramori, G., Casolari, P., Contoli, M., Johnston, S. L., & Papi, A. A. (2007) · PubMed Central · Cited by 24
Dosanjh, A., Rednam, S., & Martin, M. (2003) · Pediatric Allergy and Immunology · doi:10.1046/j.0905-6157.2003.00090.x · Cited by 23
Virus interactions with mucosal surfaces: alternative receptors, alternative pathways
Bergelson, J. M. (2003) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(03)00097-3 · Cited by 22
He, S., Zheng, J., & Duan, M.-K. (2004) · PubMed · Cited by 20
VISA—A pass to innate immunity
Qi, B., Huang, Y., Rowe, D., & Halliday, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.016 · Cited by 18
Drug Targets in Rhinoviral Infections
Rohde, G. (2009) · Infectious Disorders - Drug Targets · doi:10.2174/187152609787847695 · Cited by 17 · cited 1×
“However, due to side effects (particularly nasal bleeding and blockage), the clinical use of IFNs in asthmatic patients is limited (237).”
BackgroundImaging of lung inflammation during severe influenza A: H1N1
Bellani, G., Guerra, L., Pesenti, A. M., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1756-1 · Cited by 17
Jones, W. T., & Menna, J. H. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.791-794.1982 · Cited by 16
Airway epithelial cell–pathogen interactions
Bragonzi, A., Copreni, E., de Bentzmann, S., et al. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.05.041 · Cited by 14
Mucus Hypersecretion in Respiratory Disease
(2002) · Novartis Foundation symposium · doi:10.1002/0470860790 · Cited by 13
Rammensee, H. (2003) · Novartis Foundation symposium · doi:10.1002/0470090766.ch1 · Cited by 13
Fukasawa, C., Ishiwada, N., Ogita, J., Hishiki, H., & Kohno, Y. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aa3b2e · Cited by 6
van der Sluijs, K. F., Obregon, C., Geiser, T., Mühlemann, K., & Nicod, L. P. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0136oc · Cited by 6
Basbaum, C. (2002) · Novartis Foundation Symposia · doi:10.1002/0470860790.ch1 · Cited by 3
Interaction of bacteria and airway epithelial cells
van Alphen, L. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09071342 · Cited by 2
Mucus hypersecretion in respiratory disease. Chair's introduction.
Basbaum, C. B. (2002) · PubMed · Cited by 2
Flagged first, then by citations
Research works printed but not linked: 1
- Yang, L., Y. Luo, J. Wei, and S. He. 2010. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3. Int. J. Mol. Med. 25 : 807-812.
Cited by
Sorted by citations
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
Viral and Bacterial Interactions in the Upper Respiratory Tract
Bosch, A. A. T. M., Biesbroek, G., Trzcinski, K., Sanders, E. A. M., & Bogaert, D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003057 · Cited by 651
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02640 · Cited by 495
Metadata
- Authors
- Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N.
- Affiliations
- Division of Respiratory Medicine, Department of Pediatrics, University Children's Hospital of Bern, Inselpital, 3010 Bern, Switzerland
- University of Bern (CH)
- Asthma UK (GB)
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-01
- Volume
- 24
- Issue
- 1
- Pages
- 210-229
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3021210
- OpenAlex
- W2145181045
- Semantic Scholar
- a942a5a52b73a1f1befb07f36f25743cfed15229
- Cited by
- 655
- References
- 341
- Citations by year
- 2026: 25 · 2025: 39 · 2024: 40 · 2023: 57 · 2022: 44 · 2021: 64 · 2020: 52 · 2019: 36 · 2018: 36 · 2017: 45 · 2016: 44 · 2015: 49 · 2014: 48 · 2013: 47 · 2012: 21
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0508-10212)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- airway epithelium, respiratory viruses, innate immunity, interferon, lactoferrin, beta-defensins, nitric oxide, cytokines and chemokines, viral immune evasion, epithelial barrier integrity, mucus hypersecretion, mucostasis, lung injury, viral clearance
- MeSH terms
- Humans, Immunity, Innate, Respiratory Tract Infections, Viruses, Respiratory Mucosa, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review